CureSureMedico
Currency

Comprehensive Cancer Screening

Diagnostics

payments

Starting from

$300

Up to $2,500 depending on centre

schedule

Typical duration

2–3 days

Including pre-operative work-up

medical_services

Procedures

4

Hold to see procedures

arrow_downwardlocal_hospital

Partner hospitals

0

Vetted for outcome data & accreditation

Overview

A multi-cancer early detection program combining colonoscopy, mammography, low-dose CT lung screening, PSA testing, tumour markers, and genetic risk assessment to catch cancer at the most treatable stage. Traveling abroad for screening gives patients access to advanced oncology diagnostics at significantly lower cost.

Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.

What's included

Pre-screening oncology tele-consultation to tailor the panel to your risk profile
Full diagnostic procedures: colonoscopy, mammography, LDCT lung, PSA, and tumour marker panel
Genetic risk assessment consultation where indicated
Dedicated oncology nurse coordinator and medical interpreter throughout
Detailed cancer screening report with risk stratification and follow-up plan
Post-screening physician consultation and digital records transfer

Coordinated from

$300

or message us on WhatsApp

No commitment required. Your data is never shared with third parties.

Global cost comparison — Comprehensive Cancer Screening

Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.

CountryAvg. cost
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Best value
$500
🇹🇷

Turkey

Istanbul

$1,000

Costs are indicative and reviewed quarterly. Request a personalised estimate for your specific case.

Frequently asked questions

The standard package screens for the most prevalent cancers in the international patient population: colorectal cancer (via colonoscopy), breast cancer (via digital mammography), lung cancer (via low-dose CT, recommended for smokers and high-risk patients), prostate cancer (via PSA blood test), ovarian cancer (via CA-125 and pelvic ultrasound), and general tumour markers including CEA and AFP. An optional genetic panel can assess hereditary risk for BRCA-related breast and ovarian cancers, Lynch syndrome for colorectal cancer, and other hereditary conditions. Your coordinating oncologist will recommend the most appropriate sub-panel based on your age, sex, and family history.

No fees. No commitment.

Our guidance is completely free

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp